Paradox of a better test for Huntington's disease

Journal of Neurology Neurosurgery and Psychiatry

Volumn 69, Issue 5, 2000, Pages 579-583

  Maat Kievit, A ^a   Vegter van Der Vlis, M ^a   Zoeteweij, M ^a   Losekoot, M ^a   Van Haeringen, A ^a   Roos, R ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Huntington's disease; Mutation analysis; Predictive testing; Prenatal testing

Indexed keywords

ADOLESCENT; ADULT; AGED; ARTICLE; CHILD; DNA DETERMINATION; EVALUATION; FEMALE; GENE MUTATION; HUMAN; HUNTINGTON CHOREA; MALE; MENTAL DISEASE; NETHERLANDS; PRENATAL SCREENING; PREVALENCE; PRIORITY JOURNAL; RETROSPECTIVE STUDY; RISK ASSESSMENT;

ADULT; AGE DISTRIBUTION; AGED; FEMALE; GENETIC SCREENING; HUMANS; HUNTINGTON DISEASE; MALE; MIDDLE AGED; MUTATION; NETHERLANDS; PREDICTIVE VALUE OF TESTS; PREGNANCY; PRENATAL DIAGNOSIS; RETROSPECTIVE STUDIES; SEX DISTRIBUTION;

EID: 0033784716     PISSN: 00223050     EISSN: None     Source Type: Journal    
DOI: 10.1136/jnnp.69.5.579     Document Type: Article

References (24)

1. Harper PS. Huntington's disease. London: Saunders, 1996.
2. Gusella JF, Wexler NS, Conneally PM, et al. A polymorphic DNA marker genetically linked to Huntington's disease. Nature 1983;306:234-8.
3. Huntington's Disease Collaborative Research Group. A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington's disease chromosomes. Cell 1993;72:971-83.
4. Evers-Kieboom G, Cassiman JJ, van de Berghe H. Attitudes towards predictive testing in Huntington's disease: a recent survey in Belgium. J Med Genet 1987;24:275-9.
5. Kessler S, Field T, Worth L, et al. Attitudes of persons at risk for Huntington's disease toward predictive testing. Am J Med Genet 1987;26:259-70.
6. Teltscher B, Polgar S. Objective knowledge about Huntington's disease and attitudes towards predictive testing of persons-at risk. J Med Genet 1981;18:31-9.
7. Tyler A, Ball D, Craufurd D. Presymptomatic testing for Huntington's disease in the United Kingdom. The United Kingdom Huntington's Disease Prediction Consortium. BMJ 1992;304:1593-6.
8. Bloch M, Fahy M, Fox S, et al. Predictive testing for Huntington's disease II: Demographic characteristics, life style patterns, attitudes and psychosocial assessment of the first fifty-one test candidates. Am J Med Genet 1989;32:217-24.
9. World Federation of Neurology Research Group on Huntington's Disease. Presymptomatic testing for Huntington's disease: a worldwide survey. J Med Genet 1993;30: 1020-2.
10. Tibben A, Frets PG, van de Kamp JJP, et al. Presymptomatic DNA testing for HD: pretest attitudes and expectations of applicants and their partners in the Dutch program. Am J Med Genet 1993;48:10-61.
11. Codori AM, Hanson R, Brandt J. Self-selection in predictive testing for Huntington's disease. Am J Med Genet 1994;54: 167-73.
12. Van der Steenstraten IM, Tibben A, Roos RA, et al. Predictive testing for Huntington's disease: non-participants compared with participants in the Dutch program. Am J Hum Genet 1994;55:618-25.
13. Tibben A, Timman R, Bannink EC, et al. 3-year follow-up after presymptomatic testing for Huntington's disease in tested individuals and partners. Health Psychol 1997;26:20-35.
14. Wiggins S, Whyte P, Huggins M. The psychological consequences of predictive testing for Huntington's disease. Canadian collaborative study of predictive testing. N Engl J Med 1992;327:1401-5.
15. Almqvist E, Bloch M, Brinkman R, et al. A world-wide assessment of suicide, suicide attempts, or psychiatric hospitalisation after predictive testing for Huntington disease. Am J Hum Genet 1999;64:1293-304.
16. International Huntington Association and World Federation of Neurology Research Group on Huntington's Chorea. Ethical issues policy statement on Huntington's disease molecular genetics predictive test. J Med Genet 1990;27;34-8.
17. International Huntington Association and World Federation of Neurology Research Group on Huntington's Chorea. Guidelines for the molecular genetics predictive test in Huntington's disease. J Med Genet 1994;31:555-9.
18. Maat-Kievit A, Vegter-van de Vlis M, Zoeteweij M, Losekoot M, van Haeringen A, Roos R. Predictive testing of 25% at-risk individuals for Huntington's disease (1987-97). Am J Med Genet 1999;88:662-8.
19. Maat-Kievit A, Vegter-van de Vlis M, Zoeteweij M, et al. Ten years of experience in prenatal testing for Huntington's disease in The Netherlands: procedures, results and guidelines. Prenat Diagn 1999;19:450-7.
20. Conneally PM. Huntington disease: genetics and epidemiology. Am J Hum Genet 1985;36:506-26.
21. Harper PS, Newcombe RG. Age at onset and life table risks in genetic counselling for Huntington's disease. J Med Genet 1992;29:239-43.
22. Benjamin CM, Adam S, Wiggins S, et al. Proceed with care: direct testing for Huntington's disease. Am J Hum Genet 1994;55:606-17.
23. American College of Medical Genetics/American Society of Human Genetics. Huntington's Disease Genetic Testing Working Group. Laboratory guidelines for Huntington's disease genetic testing. Am J Hum Genet 1998;62:1243-7.
24. Kremer B, Goldberg YP, Andrew SE, et al. A worldwide study of the Huntington's disease mutation: the sensitivity and specificity of measuring CAG repeats. N Engl J Med 1994;330:1401-6.